As of March 25, about 350,000 people have enrolled for the waiting list for vaccination against coronavirus (COVID-19) disease, according to the website of the Public Health Center.
One can enroll for the vaccination waiting list from March 1 through the Diia portal or mobile application, as well as through the call center of the Ministry of Health.
The center notes that a person does not need to enroll for a waiting list if the person is:
– an employee of the healthcare, education or social sphere, working or staying in boarding schools, nursing homes, etc.;
– soldier;
– an employee of critical structures of state security.
In this case, the employer or the head of the institution will inform a person about the possibility of getting vaccinated.
Chairman of the Verkhovna Rada Dmytro Razumkov has signed an order to convene an extraordinary plenary meeting of the Rada in connection with the demand of 156 deputies, the press service of the parliament reports.
According to the released agenda, the deputies will hear information from the heads of the Security Service of Ukraine, the National Police and the State Bureau of Investigations regarding the events that took place near the building of the President’s Office on March 20, and will consider a draft resolution No. 5295 condemning these events.
The agenda also provides for the consideration of draft resolutions on the early termination of the powers of MPs Oleksandr Skychko and Ihor Kolykhayev, as well as on the appointment of early elections for the mayor of Kharkiv and Shehyni rural head in Lviv region.
The second batch of the coronavirus (COVID-19) vaccine from the Chinese manufacturer Sinovac Biotech is expected in the coming weeks, Ukrainian President Volodymyr Zelensky said.
He said that the signed contract provides for the receipt of almost 2 million doses, according to the presidential press service.
“In addition to China, the Sinovac vaccine is already used by 18 countries of the world. In particular, Turkey, where President Erdogan and Patriarch Bartholomew were vaccinated with it,” Zelensky said.
As reported, on Thursday evening, March 25, the first batch of the Chinese COVID-19 vaccine CoronaVac, produced by the Chinese company Sinovac Biotech, in amount of 215,000 doses, arrived at Boryspil International Airport.
The independent laboratory Invitro will conduct research on the effectiveness of the vaccine CoviShield/AstraZeneca, a press release of the company says.
Head of the laboratory’s clinical diagnostic complex Pavlo Naboka said that the study will consist in checking the amount of antibodies that were produced after vaccination.
“According to the official instructions, the principle of action of the CoviShield vaccine is based on the development of specific immunity to the S-protein (spike) of the SARS-CoV-2 coronavirus (the causative agent of COVID-19). The presence of a sufficient amount of antibodies to this protein is a factor that protects a person from the development of the disease even in case of infection. It is possible to check how many antibodies have developed in the body after vaccination by using a new laboratory test by the world famous manufacturer Abbott Diagnostics to quantify the level of neutralizing (protective) antibo
During the entire COVID-19 vaccination process, blood samples will be taken from laboratory staff to monitor immune levels, he said. That is, the laboratory will assess how many antibodies to SARS-CoV-2 will appear in a person after the first and second vaccinations, at what rate of antibodies will be produced, whether the actual concentration of antibodies will correspond to the data reported by the vaccine manufacturer.
According to the instructions, a sufficient level of antibodies should be formed within 90 days after the first administration of the vaccine. That is, the laboratory Invitro will be able to announce the results of the study in the summer of 2021.
AstraZeneca, COVISHIELD, EFFECTIVENESS, INDEPENDENT LABORATORY, VACCINE
Interpipe, the international vertically integrated pipe and wheel company, continues to develop the export of premium pipe products by supplying premium pipes UPJ-F to Uzbekistan.
“We continue to develop the export of our premium products. This time, the Ukrainian industrial company Interpipe has successfully supplied casing pipes with a premium UPJ-F sleeveless connection to our permanent partner Uzbekneftegaz, the national holding corporation of Uzbekistan,” Interpipe said on Facebook.
At the same time, it is explained that this company is engaged in geological exploration, production and processing of oil and gas. Interpipe has been cooperating with it for several years, selling pipe products for the construction of oil and gas wells. But this order is special: Interpipe for the first time delivered 500 tonnes of UPJ-F casing to a client from the CIS, the report explains.
“The complexity of the order consisted not only in high-precision production, the client asked to ship the first batch as soon as possible. In total, over the past six months, Interpipe has supplied Uzbekneftegaz with almost 2,000 tonnes of pipes of various assortments,” the group said in a press release.
The company expects that the supply of premium products to gas wells in Uzbekistan will strengthen the position of Interpipe in the market of sleeveless connections in the Central Asian region.
Interpipe is a Ukrainian industrial company, a manufacturer of seamless pipes and railway wheels. The company’s products are supplied to more than 80 countries around the world through a network of sales offices located in key markets of the CIS, the Middle East, North America and Europe.
Ukraine expects to start receiving Indian vaccines against COVID-19 in early April, Health Minister Maksym Stepanov said.
“We see that there is a corresponding problem, and we are monitoring the political processes that are taking place in India, that they have withheld vaccines for everyone, without exception. But I think that this delay will not last too long. I think that nevertheless, somewhere in early April, we must obtain permission and start receiving vaccines from India. I am optimistic about this,” Stepanov said on the air of Right to Power (Pravo na Vladu) program on the 1 + 1 TV channel on Thursday evening, March 25.
